| |
| |
|
| Insider
Information: |
Poradosu Enrique |
| Relationship: |
Chief Science & Busine... |
| City: |
Fort Lee |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,503,819 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,503,819 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvectis Pharma, Inc. |
NVCT |
Chief Science & Busine... |
2024-01-03 |
1,503,819 |
2022-02-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVCT |
Nuvectis Pharma, Inc. |
Chief Science & Business Off |
• – – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
130,000 |
1,503,819 |
0 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Science & Business Off |
• – – |
2023-03-27 |
4 |
B |
$11.55 |
$5,775 |
D/D |
500 |
1,373,819 |
2.74 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Science & Business Off |
• – – |
2023-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
1,373,319 |
0 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Science & Business Off |
• – – |
2022-05-12 |
4 |
B |
$14.76 |
$10,273 |
D/D |
670 |
1,258,319 |
2.74 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Science & Business Off |
• – – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
1,257,649 |
0 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Science & Business Off |
• – – |
2022-02-07 |
4 |
B |
$3.88 |
$3,104 |
D/D |
800 |
1,197,649 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Science & Business Off |
• – – |
2022-02-04 |
4 |
B |
$3.35 |
$12,730 |
D/D |
3,800 |
1,196,849 |
2.74 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
